Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Chickenpox Stories

2011-05-12 10:42:34

Administering both the pneumococcal and the herpes zoster vaccines to patients during the same visit is beneficial and does not appear to compromise the protective effect of the zoster vaccine, according to a Kaiser Permanente study published today in the journal Vaccine. The study's findings challenge information in the zoster vaccine manufacturer's package insert. This new information is important to patients who find it more convenient and less costly to receive both vaccines from their...

2011-05-11 18:00:00

PASADENA, Calif., May 11, 2011 /PRNewswire/ -- Administering both the pneumococcal and the herpes zoster vaccines to patients during the same visit is beneficial and does not appear to compromise the protective effect of the zoster vaccine, according to a Kaiser Permanente study published today in the journal Vaccine. The study's findings challenge information in the zoster vaccine manufacturer's package insert. This new information is important to patients who find it more convenient and...

2011-04-22 12:48:18

Back with a vengeance Researchers at the University of Georgia and Yale University have discovered a compound with the potential to be more effective than existing agents in treating the very painful blisters known as shingles"”a condition that affects up to 30 percent of Americans, mostly elderly, and for which no specific treatment exists. Most adults remember the fever, itchy blisters and possibly tiny scars they experienced as children when they had chickenpox, which is caused by...

2011-03-24 14:57:00

SILVER SPRING, Md., March 24, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year....

2011-02-24 15:37:21

New study from University of Montreal evaluates impact of steroid use on immune system Children experiencing an asthma attack who are treated with a short burst of oral steroids may have a transient depression of immune response according to a new study led by Universit© de Montr©al. These findings, published in this month's issue of Pediatric Allergy, Immunology and Pulmonology, have implications for asthmatic children who have flare-ups and who may be exposed to new contagious...

2011-02-24 09:24:14

(Ivanhoe Newswire) -- Patients with chronic obstructive pulmonary disease (COPD) are at a greater risk for contracting shingles compared with the general population. The risk is greatest for COPD patients taking oral steroids, according to this study. Shingles, or herpes zoster, is a reactivation of the chicken pox virus resulting in a painful rash with lesions. People with a compromised immune system are at greater risk of developing shingles although it has not been previously studied in...

2011-02-22 21:42:02

Patients with chronic obstructive pulmonary disease (COPD) are at greater risk of shingles compared with the general population, according to a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj101137.pdf. The risk is greatest for patients taking oral steroids to treat COPD. Shingles, or herpes zoster, is a reactivation of the chicken pox virus resulting in a painful rash with lesions. People with a compromised immune system...

2011-01-12 14:11:24

Kaiser Permanente research strengthens national recommendations Receiving the herpes zoster vaccine was associated with a 55 percent reduced risk of developing shingles, according to a Kaiser Permanente study of 300,000 people that appears in the current issue of the Journal of the American Medical Association. This retrospective study observed the outcomes of the effectiveness of the herpes zoster vaccine in a large, diverse population of men and women ages 60 years and older. Researchers...

2011-01-12 07:43:36

(Ivanhoe Newswire) -- There are more than 1 million episodes of shingles every year in the United States. It is a painful condition that can last months or years and can seriously impact quality of life. Getting the herpes zoster vaccine was associated with a 55-percent reduced risk of developing shingles, according to a new study. This study observed the outcomes of the effectiveness of the herpes zoster vaccine in a large, diverse population of men and women ages 60 years and older....

2011-01-07 07:21:16

(Ivanhoe Newswire) -- Two doses of the chickenpox vaccine provide excellent protection in children against the highly-contagious itchy disease, according to a new study. The Centers for Disease Control and Prevention (CDC) began recommending a single dose of chickenpox vaccine in children aged 1 to 13 years old in 1995. Although the incidence of chickenpox fell by 90 percent after introduction of the vaccine, there was a high rate of breakthrough chickenpox illness in immunized children and...


Latest Chickenpox Reference Libraries

69_7b87211f9314eacab994d465558a3a1b
2011-01-24 12:56:26

Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...

More Articles (1 articles) »